Medical-Grade Honey for Pressure Injuries
Medical-grade honey should be considered as an effective treatment option for pressure injuries, particularly for stages 1-3 wounds and clinically infected pressure ulcers, though it is not specifically recommended in current American College of Physicians guidelines. 1
Guideline Framework
The 2015 ACP guideline for pressure ulcer treatment recommends hydrocolloid or foam dressings and does not specifically address medical-grade honey as a treatment modality. 1 The guideline focuses on protein/amino acid supplementation, hydrocolloid/foam dressings, and electrical stimulation as evidence-based interventions. 1 This represents a gap between guideline recommendations and emerging clinical evidence for honey-based therapies.
When to Add Medical-Grade Honey
Primary Indications:
Stages 1-3 pressure injuries: Medical-grade honey accelerates healing with median time to complete healing of 7 days versus 9 days with standard care (hazard ratio 1.86, meaning 1.9-fold increased likelihood of complete healing at any given time). 2
Clinically infected pressure ulcers: Particularly effective for hard-to-heal wounds that have failed previous treatments with topical antibiotics or antiseptics, achieving infection resolution within 3-4 weeks. 3
Infected post-operative wounds: Honey heals these wounds more quickly than antiseptic washes followed by gauze (RR of healing 1.69). 4
Patient Populations Where Evidence is Strongest:
Critically ill children: Demonstrated superior outcomes in pediatric ICU patients with pressure injuries at bony prominences and face mask contact points. 2
High-risk elderly patients: Effective in patients with advanced age (median 86 years), multiple comorbidities, and permanent immobility where conventional treatments failed. 3
Heel pressure ulcers: Specific evidence supports use in clinically infected heel pressure ulcers in high-risk patients. 3
Clinical Advantages Over Standard Care
Healing velocity: Honey-treated pressure ulcers demonstrate approximately 4 times the healing rate compared to ethoxy-diaminoacridine plus nitrofurazone dressings at 5 weeks. 5
Safety profile: No allergic reactions or secondary wound infections reported in pediatric critical care trials, and fewer adverse events compared to silver sulfadiazine. 2, 4
Antimicrobial activity: Broad-spectrum antimicrobial properties make honey particularly valuable for infected wounds where antibiotic resistance is a concern. 3, 6
Critical Implementation Details
Product Selection:
Use only medical-grade honey products (such as Manuka or active Leptospermum honey, L-Mesitran) that meet stringent criteria: organically produced, gamma sterilized, adherent to clinical safety benchmarks, and proven biological activity including antimicrobial and antioxidant properties. 2, 3, 7
Contraindications:
- Patients on more than two inotropes 2
- Signs of acute wound infection requiring systemic antibiotics 2
- Wounds greater than 5 cm diameter 2
- Known allergy to honey 2
Evidence Quality Considerations
The Cochrane review notes that evidence quality for honey in pressure injuries is very low (1 trial, n=40), though honey healed pressure ulcers more quickly than saline soaks (RR 1.41). 4 However, more recent high-quality evidence from the 2021 multicenter RCT in critically ill children provides stronger support for honey's efficacy in this specific population. 2
Common pitfall: The 2015 Cochrane review concluded that evidence was insufficient to form a robust basis for decision-making across all wound types, but this predates the 2021 pediatric trial which provides higher-quality evidence for pressure injuries specifically. 4, 2
Practical Algorithm
- Assess wound characteristics: Stage 1-3 pressure injury with or without clinical infection
- Screen for contraindications: Check inotrope use, wound size, allergy history
- Consider patient risk factors: High-risk patients (elderly, immobile, multiple comorbidities) or critically ill children are ideal candidates
- Select appropriate MGH product: Use gamma-sterilized, medical-grade honey (Manuka/Leptospermum-based)
- Apply as primary dressing: Replace standard care dressings with honey-based products
- Monitor response: Expect infection resolution within 3-4 weeks and complete healing within 7-10 days for uncomplicated wounds 2, 3
Cost-effectiveness consideration: MGH products are clinically and cost-effective for hard-to-heal pressure ulcers, particularly when previous treatments have failed. 3